LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. FMHR. 2026;4(3):3196-3217. Accessed November 8, 2026. https://fmhr.net/index.php/fmhr/article/view/3537